Carl Zeiss Meditec Ag
(OTC) CZMWF
Carl Zeiss Meditec Ag Financials at a Glance
Market Cap
$2.63B
Revenue (TTM)
€3.19B
Net Income (TTM)
€90.00M
EPS (TTM)
$1.25
P/E Ratio
24.00
Dividend
$0.63
Beta (Volatility)
0.15 (Low)
Dividend
$0.63
Beta (Volatility)
0.15 (Low)
Price
$30.00
Volume
100
Open
$30.00
Price
$30.00
Volume
100
Open
$30.00
Previous Close
$30.00
Daily Range
$30.00 - $30.00
52-Week Range
$26.42 - $67.24
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.63
Beta (Volatility)
0.15 (Low)
Price
$30.00
Volume
100
Open
$30.00
Previous Close
$30.00
Daily Range
$30.00 - $30.00
52-Week Range
$26.42 - $67.24
Estimated Earnings Date
Aug 6, 2026
CZMWF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Carl Zeiss Meditec Ag
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
5,784
CEO
Maximilian Foerst
Website
www.zeiss.deHeadquarters
Jena, 07745, DE
CZMWF Financials
Key Financial Metrics (TTM)
Gross Margin
50.81%
Operating Margin
6.15%
Net Income Margin
3.41%
Return on Equity
4.29%
Return on Capital
9.93%
Return on Assets
2.69%
Earnings Yield
4.17%
Dividend Yield
2.10%
Payout Ratio
1.12%
Stock Overview
Market Cap
$2.63B
Shares Outstanding
87.54M
Volume
100
Avg. Volume
113.952
Financials (TTM)
Gross Profit
€1.63B
Operating Income
€162.29M
EBITDA
€384.40M
Operating Cash Flow
€393.02M
Capital Expenditure
-€28.09M
Free Cash Flow
€365.19M
Cash & ST Invst.
€23.99M
Total Debt
€619.90M
Carl Zeiss Meditec Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€994.74M
+77.6%
Gross Profit
€492.38M
+63.2%
Gross Margin
49.50%
N/A
Market Cap
$2.63B
N/A
Market Cap/Employee
$454.03K
N/A
Employees
5,784
N/A
Net Income
€14.72M
-67.5%
EBITDA
€113.89M
+12.9%
Quarterly Fundamentals
Total Cash
€23.99M
+18.3%
Total Debt
€619.90M
N/A
Accounts Receivable
€626.07M
N/A
Inventory
€540.60M
N/A
Long Term Debt
€559.85M
N/A
Short Term Debt
€60.05M
N/A
Return on Assets
2.69%
N/A
Return on Invested Capital
5.73%
N/A
Free Cash Flow
€89.20M
+439.2%
Operating Cash Flow
€99.29M
+477.5%